AMED
Price
$97.94
Change
+$0.11 (+0.11%)
Updated
Jul 25 closing price
Capitalization
3.02B
One day until earnings call
USPH
Price
$74.25
Change
-$0.08 (-0.11%)
Updated
Jul 25 closing price
Capitalization
1.69B
10 days until earnings call
Interact to see
Advertisement

AMED vs USPH

Header iconAMED vs USPH Comparison
Open Charts AMED vs USPHBanner chart's image
Amedisys
Price$97.94
Change+$0.11 (+0.11%)
Volume$417.52K
Capitalization3.02B
US Physical Therapy
Price$74.25
Change-$0.08 (-0.11%)
Volume$102.65K
Capitalization1.69B
AMED vs USPH Comparison Chart in %
Loading...
AMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
USPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMED vs. USPH commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMED is a Hold and USPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (AMED: $97.94 vs. USPH: $74.25)
Brand notoriety: AMED and USPH are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: AMED: 113% vs. USPH: 56%
Market capitalization -- AMED: $3.02B vs. USPH: $1.69B
AMED [@Medical/Nursing Services] is valued at $3.02B. USPH’s [@Medical/Nursing Services] market capitalization is $1.69B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $88.21B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $4.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMED’s FA Score shows that 0 FA rating(s) are green whileUSPH’s FA Score has 0 green FA rating(s).

  • AMED’s FA Score: 0 green, 5 red.
  • USPH’s FA Score: 0 green, 5 red.
According to our system of comparison, both AMED and USPH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMED’s TA Score shows that 4 TA indicator(s) are bullish while USPH’s TA Score has 2 bullish TA indicator(s).

  • AMED’s TA Score: 4 bullish, 4 bearish.
  • USPH’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, AMED is a better buy in the short-term than USPH.

Price Growth

AMED (@Medical/Nursing Services) experienced а +0.49% price change this week, while USPH (@Medical/Nursing Services) price change was +0.34% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.28%. For the same industry, the average monthly price growth was +0.52%, and the average quarterly price growth was -0.46%.

Reported Earning Dates

AMED is expected to report earnings on Jul 28, 2025.

USPH is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.28% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMED($3.02B) has a higher market cap than USPH($1.69B). AMED has higher P/E ratio than USPH: AMED (1170.50) vs USPH (87.62). AMED YTD gains are higher at: 7.875 vs. USPH (-15.315). AMED has higher annual earnings (EBITDA): 129M vs. USPH (74.4M). USPH has more cash in the bank: 153M vs. AMED (126M). USPH has less debt than AMED: USPH (259M) vs AMED (487M). AMED has higher revenues than USPH: AMED (2.24B) vs USPH (605M).
AMEDUSPHAMED / USPH
Capitalization3.02B1.69B179%
EBITDA129M74.4M173%
Gain YTD7.875-15.315-51%
P/E Ratio1170.5087.621,336%
Revenue2.24B605M370%
Total Cash126M153M82%
Total Debt487M259M188%
FUNDAMENTALS RATINGS
AMED vs USPH: Fundamental Ratings
AMED
USPH
OUTLOOK RATING
1..100
769
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
34
Fair valued
PROFIT vs RISK RATING
1..100
10097
SMR RATING
1..100
7779
PRICE GROWTH RATING
1..100
5663
P/E GROWTH RATING
1..100
4997
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

USPH's Valuation (34) in the Medical Or Nursing Services industry is somewhat better than the same rating for AMED (78). This means that USPH’s stock grew somewhat faster than AMED’s over the last 12 months.

USPH's Profit vs Risk Rating (97) in the Medical Or Nursing Services industry is in the same range as AMED (100). This means that USPH’s stock grew similarly to AMED’s over the last 12 months.

AMED's SMR Rating (77) in the Medical Or Nursing Services industry is in the same range as USPH (79). This means that AMED’s stock grew similarly to USPH’s over the last 12 months.

AMED's Price Growth Rating (56) in the Medical Or Nursing Services industry is in the same range as USPH (63). This means that AMED’s stock grew similarly to USPH’s over the last 12 months.

AMED's P/E Growth Rating (49) in the Medical Or Nursing Services industry is somewhat better than the same rating for USPH (97). This means that AMED’s stock grew somewhat faster than USPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMEDUSPH
RSI
ODDS (%)
Bearish Trend 3 days ago
34%
Bearish Trend 3 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
57%
Bullish Trend 3 days ago
73%
Momentum
ODDS (%)
Bullish Trend 3 days ago
50%
Bearish Trend 3 days ago
64%
MACD
ODDS (%)
Bearish Trend 3 days ago
42%
Bearish Trend 3 days ago
55%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
45%
Bullish Trend 3 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
36%
Bearish Trend 3 days ago
67%
Advances
ODDS (%)
Bullish Trend 3 days ago
49%
Bullish Trend 5 days ago
64%
Declines
ODDS (%)
Bearish Trend 10 days ago
57%
Bearish Trend 3 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
45%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
43%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
USPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RPMGX102.910.52
+0.51%
T. Rowe Price Mid-Cap Growth
USCGX14.000.04
+0.29%
Victory Capital Growth
HNCYX21.440.02
+0.09%
Hartford International Growth Y
JOHIX26.47-0.19
-0.71%
JOHCM International Select Institutional
HUSIX27.29-0.26
-0.94%
Huber Small Cap Value Inv

AMED and

Correlation & Price change

A.I.dvisor tells us that AMED and FMCQF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMED and FMCQF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMED
1D Price
Change %
AMED100%
+0.11%
FMCQF - AMED
24%
Poorly correlated
N/A
OPCH - AMED
23%
Poorly correlated
+0.75%
USPH - AMED
21%
Poorly correlated
-0.11%
EHAB - AMED
21%
Poorly correlated
-2.03%
BKD - AMED
20%
Poorly correlated
+0.94%
More

USPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, USPH has been loosely correlated with NHC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if USPH jumps, then NHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To USPH
1D Price
Change %
USPH100%
-0.11%
NHC - USPH
52%
Loosely correlated
+2.03%
ENSG - USPH
43%
Loosely correlated
+8.92%
SEM - USPH
42%
Loosely correlated
+0.85%
JYNT - USPH
37%
Loosely correlated
+0.26%
SNDA - USPH
36%
Loosely correlated
-0.33%
More